The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021.
Dr. Reddy's will be the exclusive distributor of several of MediCane's medical cannabis products in Germany.
Additionally, Dr. Reddy's and MediCane have entered into a collaboration and co-funding arrangement relating to a phase II clinical trial for a medicinal cannabis product aimed at symptom relief of Behavioral and Psychological Symptoms of Dementia (BPSD). When launched, Dr. Reddy's holds exclusive sales and marketing rights for the product in Europe (except Russia and CIS countries).
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.